Cargando…

P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays

Detalles Bibliográficos
Autores principales: Brown, BK, Lombardi, K, Bryson, M, Currier, J, Thelian, D, Wieczorek, L, Kijak, G, Kappes, JC, Ochsenbauer-Jambor, C, Michael, NL, Montefiori, D, Polonis, VR
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767915/
http://dx.doi.org/10.1186/1742-4690-6-S3-P40
_version_ 1782173407790497792
author Brown, BK
Lombardi, K
Bryson, M
Currier, J
Thelian, D
Wieczorek, L
Kijak, G
Kappes, JC
Ochsenbauer-Jambor, C
Michael, NL
Montefiori, D
Polonis, VR
author_facet Brown, BK
Lombardi, K
Bryson, M
Currier, J
Thelian, D
Wieczorek, L
Kijak, G
Kappes, JC
Ochsenbauer-Jambor, C
Michael, NL
Montefiori, D
Polonis, VR
author_sort Brown, BK
collection PubMed
description
format Text
id pubmed-2767915
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27679152009-10-28 P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays Brown, BK Lombardi, K Bryson, M Currier, J Thelian, D Wieczorek, L Kijak, G Kappes, JC Ochsenbauer-Jambor, C Michael, NL Montefiori, D Polonis, VR Retrovirology Poster Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767915/ http://dx.doi.org/10.1186/1742-4690-6-S3-P40 Text en Copyright © 2009 Brown et al; licensee BioMed Central Ltd.
spellingShingle Poster Presentation
Brown, BK
Lombardi, K
Bryson, M
Currier, J
Thelian, D
Wieczorek, L
Kijak, G
Kappes, JC
Ochsenbauer-Jambor, C
Michael, NL
Montefiori, D
Polonis, VR
P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
title P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
title_full P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
title_fullStr P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
title_full_unstemmed P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
title_short P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
title_sort p04-12. characterization of leukopak pbmc phenotypes and biotypes for optimal performance in hiv-1 neutralization assays
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767915/
http://dx.doi.org/10.1186/1742-4690-6-S3-P40
work_keys_str_mv AT brownbk p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT lombardik p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT brysonm p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT currierj p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT theliand p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT wieczorekl p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT kijakg p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT kappesjc p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT ochsenbauerjamborc p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT michaelnl p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT montefiorid p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays
AT polonisvr p0412characterizationofleukopakpbmcphenotypesandbiotypesforoptimalperformanceinhiv1neutralizationassays